Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Big Pharma Outlook 2025, An Infographic

Executive Summary

Big Pharma is poised for growth because of strong launch portfolios, the availability of high-potential pipeline assets, and a focus on high-performing markets. This outlook has been created using in-house sales forecasts from the 16 companies that form Datamonitor Healthcare's Big Pharma peer set.

Infographic: Big Pharma Outlook to 2025

[Editor’s note: For more information, see Datamonitor Healthcare’s in-depth Big Pharma Outlook report]





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts